Leap Therapeutics Inc (LPTX)
NASDAQ
Quarter End | 12 2022 | 3 2023 | 6 2023 | 9 2023 | 12 2023 | 3 2024 | 6 2024 | 9 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -13.94M | -42.73M | -14.66M | -14.83M | -14.82M | -14.83M | -21.25M | -17.86M |
税引前収入 | -11.96M | -41.86M | -13.39M | -13.7M | -12.47M | -13.82M | -20.13M | -17.47M |
純利益 | -12.1M | -41.86M | -13.39M | -13.7M | -12.47M | -13.82M | -20.13M | -18.41M |
優先配当 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -234k |
基本的1株当たり利益 (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -13.17M | -42.45M | -14.36M | -14.28M | -14.34M | -14.58M | -21M | -17.86M |
EBITDA | -13.94M | -42.72M | -14.66M | -14.83M | -14.82M | -14.82M | -21.25M | -17.86M |
年末 2023年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 1.5M | 1.5M | 0 | 0 |
営業利益 | -27.52M | -32.35M | -30.75M | -33.45M | -28.54M | -41.43M | -56.76M | -87.04M |
税引前収入 | -25.63M | -29.88M | -23.12M | -32.9M | -27.52M | -40.61M | -54.45M | -81.41M |
純利益 | -25.63M | -29.97M | -23.14M | -33.26M | -37.59M | -40.59M | -54.6M | -81.41M |
優先配当 | 0 | 0 | 0 | 0 | -372k | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -0.496 | -0.549 | -0.406 | -0.5 | -0.369 | -0.311 | -0.386 | -1.2 |
EBIT | -24.4M | -30.69M | -30M | -33.32M | -28.31M | -40.2M | -54.71M | -85.44M |
EBITDA | -27.5M | -32.3M | -30.7M | -33.4M | -28.51M | -41.4M | -56.75M | -87.03M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約